Loading clinical trials...
Loading clinical trials...
Safety of Nasal Influenza Immunisation in Children With Asthma - The SNIFFLE-4 Study
Conditions
Interventions
Administration of Live attenuated influenza vaccine (LAIV)
Start Date
October 1, 2016
Primary Completion Date
March 1, 2017
Completion Date
March 1, 2017
Last Updated
May 10, 2019
NCT02327897
NCT07219173
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Imperial College London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions